These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2389686)

  • 21. Time course of serum cardiac enzymes after intracoronary thrombolytic therapy. Creatine kinase, creatine kinase MB isozyme, lactate dehydrogenase, and serum glutamic-oxaloacetic transaminase.
    Wei JY; Markis JE; Malagold M; Grossman W
    Arch Intern Med; 1985 Sep; 145(9):1596-600. PubMed ID: 4026489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Intravenous thrombolysis in acute myocardial infarct].
    Schröder R
    Z Kardiol; 1986; 75 Suppl 5():93-100. PubMed ID: 3825231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Usefulness of a rapid initial increase in plasma creatine kinase activity as a marker of reperfusion during thrombolytic therapy for acute myocardial infarction.
    Lewis BS; Ganz W; Laramee P; Cercek B; Hod H; Shah PK; Lew AS
    Am J Cardiol; 1988 Jul; 62(1):20-4. PubMed ID: 3381752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized trial of intravenous and intracoronary streptokinase in patients with acute myocardial infarction.
    Anderson JL; Marshall HW; Askins JC; Lutz JR; Sorensen SG; Menlove RL; Yanowitz FG; Hagan AD
    Circulation; 1984 Oct; 70(4):606-18. PubMed ID: 6383654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced infarct size in nonreperfused myocardial infarction by combined infusion of isosorbide dinitrate and streptokinase.
    Hildebrandt P; Torp-Pedersen C; Joen T; Iversen E; Jensen G; Jeppesen D; Melchior T; Schytten HJ; Ringsdal V; Jensen J
    Am Heart J; 1992 Nov; 124(5):1139-44. PubMed ID: 1442478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Timing of ischemic onset estimated from the electrocardiogram is better than historical timing for predicting outcome after reperfusion therapy for acute anterior myocardial infarction: a DANish trial in Acute Myocardial Infarction 2 (DANAMI-2) substudy.
    Sejersten M; Ripa RS; Maynard C; Grande P; Andersen HR; Wagner GS; Clemmensen P;
    Am Heart J; 2007 Jul; 154(1):61.e1-8. PubMed ID: 17584552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary percutaneous transluminal coronary angioplasty accelerates early myocardial reperfusion compared to thrombolytic therapy in patients with acute myocardial infarction.
    Zeymer U; Schröder R; Machnig T; Neuhaus KL
    Am Heart J; 2003 Oct; 146(4):686-91. PubMed ID: 14564324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time course and characteristics of ventricular arrhythmias after reperfusion in acute myocardial infarction.
    Cercek B; Lew AS; Laramee P; Shah PK; Peter TC; Ganz W
    Am J Cardiol; 1987 Aug; 60(4):214-8. PubMed ID: 2441585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ST-segment analysis: a useful marker for reperfusion after thrombolysis with APSAC? The Belgian EMS Study Group.
    Bossaert L; Conraads V; Pintens H
    Eur Heart J; 1991 Mar; 12(3):357-62. PubMed ID: 2040318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of thrombolytic therapy with intravenous streptokinase on the size of myocardial infarction estimated by the ECG QRS score system].
    Machavariani PT; Agladze VT; Iosava LI; Tsirekidze OU; Iosava KV
    Kardiologiia; 1992 May; 32(5):67-70. PubMed ID: 1405268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Indirect criteria of coronary reperfusion and permeability in patients with acute myocardial infarction who have received thrombolytic therapy].
    Pereira MA; Albuquerque A; Azevedo JG; Torres S; Gomes L; Campos M; Pimenta A
    Rev Port Cardiol; 1991 Mar; 10(3):229-35. PubMed ID: 1854515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Noninvasive markers of intravenous streptokinase coronary thrombolysis.
    Udall JA
    Clin Cardiol; 1983 Feb; 6(2):86-96. PubMed ID: 6831789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous streptokinase treatment and serum C-reactive protein in patients with acute myocardial infarction.
    Pietilä K; Harmoinen A; Pöyhönen L; Koskinen M; Heikkila J; Ruosteenoja R
    Br Heart J; 1987 Sep; 58(3):225-9. PubMed ID: 3663422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "Mirror-lake" serial relationship of electrocardiographic and biochemical indices for the detection of reperfusion and the prediction of salvage in patients with acute myocardial infarction.
    Jurlander B; Holmvang L; Galatius S; Vaught C; Johanson P; Krucoff MW; Grande P; Clemmensen P; Wagner GS
    Am Heart J; 2003 Nov; 146(5):757-63. PubMed ID: 14597923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reperfusion arrhythmias during coronary reperfusion therapy in man. Clinical and angiographic correlations.
    Buckingham TA; Devine JE; Redd RM; Kennedy HL
    Chest; 1986 Sep; 90(3):346-51. PubMed ID: 3743145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and efficacy of thrombolysis with alteplase (50 mg) plus tirofiban versus alteplase (100 mg) alone in acute myocardial infarction: preliminary findings.
    Sarullo FM; Pasquale PD; D'Alfonso G; Amerigo L; Cannizzaro S; Castello A
    Ital Heart J; 2001 Aug; 2(8):605-11. PubMed ID: 11577835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of thrombolytic therapy with anisoylated plasminogen streptokinase activator complex on the indicators of myocardial salvage.
    Buchalter MB; Bourke JP; Jennings K; Adams PC; Kenmure AC; Hah CW; Reid DS
    Drugs; 1987; 33 Suppl 3():209-15. PubMed ID: 3315593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The Italian Group for the Study of Streptokinase in Myocardial Infarct: Study of electrocardiographic changes].
    Piccolo E; Delise P; Zuin G; Bonso A; Romano S; Ricciardiello V; Fischer D; Tani F; Forleo C; Portulano V
    G Ital Cardiol; 1987 Jan; 17(1):57-62. PubMed ID: 3552839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential diagnosis of patients with abnormal serum creatine kinase isoenzymes.
    Lott JA; Stang JM
    Clin Lab Med; 1989 Dec; 9(4):627-42. PubMed ID: 2686905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Controversial indications. Rationale for thrombolysis: later than 4-6 h from symptom onset, and in patients with smaller myocardial infarctions. The ISAM Study Group.
    Schröder R; Linderer T; Brüggemann T; Neuhaus KL; Tebbe U; Wegscheider K
    Eur Heart J; 1990 Aug; 11 Suppl F():19-28. PubMed ID: 2226538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.